µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º e'
`xU
Qoj}]jve
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ 4zF|}aiQ
<z>K{:+>
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) ")q{>tV
UL/|!(s
1. ICAM-1 n&. bs7N2
Z66b>.<8
2. interleukin 12(IL-12) JJvf!]
I6]|dA3G
3. tumor infiltrating lymphocyte /S]W<8d
`.# l_-U{
4. TCR/CD3 complex 2p( M`@
w"CcWng1
5. hematopoietin receptor family CfMq?.4%E}
qAH@)}
6. individual idiotype(IdI) ;Yrg4/Ipa
H=vrF - #
7. integrin k'N `5M)
)x.}B4z
8. colony-stimulatory factor (CSF) (~oUd4
/&=E=S6
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© d:0RDK-}s
Y[gj2vNe4g
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? bz_Zk
V *=To
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ tRYMK+
<@n/[ +3
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ88}c+V+N!
XM3N>OR.
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ OiX>^_iDt
lhTjG,U=
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) s+>""yi
n6;jIf|
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ X'Q$v~/
\pZ,gF;y
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) o)'T#uK
\`o+Le+%
3. immunoglobulin superfamily (IgSF) oK@!yYv
[AQ6ads)
4. selectin aQwc Py|1R
>/1N#S#9
5. anti-idiotypic antibody (¦ÁId) xh[Mmq/R
*. l,_68
6. major histocompatibility complex(MHC) [o
<R#f`
T5NO}bz
7. immunotolerance ~WU
_u,:
,Cj1S7GFR
8. biological reponse modifier(BRM) 2}>jq8Y47
mJR vC%
9. immune reponse gene (Ir gene) +:?-Xd:p
BKfcK>%g
10. reshaped antibody (or reconstituted antibody) R!;tF|]
_KC)f'Cx
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© \v{tK;
d*Dq=.F(
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ bKj#HHy\I
r^-3( 77n
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? ct=|y(_
zg2A$Fd[j
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ E{sTxOI$
L B1ui
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? N,V%/O{Y
PmyS6a@
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ {co(w
7
"12.Bi.O"[
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? kc^Q?-?
I
\zM\^S>]
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ %5 0}oD@
X+;Ivx
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ KL,=Z&.<=
Mz#
&"WjF
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? -q|K\>tgU
"{105&c\
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 6|wiZw
eWS[|'dl
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: xCFk1%qf
=:n>yZ3T
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: vt<r_&+ pJ
8PB(<|}u
̉񧄤 >J^bs &j
ZQ9!k*
^
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ne] |\]
v]\io#
1. CD8 CdgZq\
dqO!p6
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) }UJS*m R
>;kCcfS3ct
3. immunoglobulin fold(Ig fold) $7eO33Bm
BlUl5mP}>
4. cadherin (Ca-dependent cell adhesion moleculers) a5ZU"6Hi
l?
v`kAMR
5. idiotype-anti-idiotypic antibody immune network theory QEK,mc3
n0g,r/
6. HLA class II antigen 5_Yl!=
<
.&t'W
7. complementarity-determining region (CDR) 2-5AKm@K
. [DCL
8. perforin(or pore-forming protein ,PFP) $~vy,^
ON#\W>MK?
9. high affinity IL-2 receptor P5/K?I~/So
#A<|hh
10. artificial active immunization yL/EIN
5Nc~cD%0tK
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© RaT(^b(
`3+yu'
Q'
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠsu6x
okt
Li~(kw3
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 It'hmwu#
u4TU"r("A
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ amq]&.M
[^xLK
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ 4DI.RK9
*0]E4]ZO
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ UMR0S5`}
^2E\{$J
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ^$qr6+
*A C){M
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ vmdu9"H
@Ee{ GH^-
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ G)5w_^&%
)6U&^9=
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ K] ;`
%!%G\nv
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ [kwVxaI
_mVq9nBEf
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© *,qW9z
D?;8bI%"
1. immunoglobulin gene rearrangement SXX6EIJr|
\|
qr&(PG
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) 1L722I@
F
FHk0!3
3. flow cytometry(FCM) d]Y-^&]{]
E
fA*w/y
4. carrier effect 0}:- t^P
r #H(kJu,
5. positive selection of T lymphocytes in thymus |"V]$s$ c
2<&lrsh
6. mouse TH1(Th1) and TH2(Th2) subsets ]pUf[^4
9MfBsp}c
7. perforin (pore-forming protein ,PFP) qMy>:,)Z
AIZs^
`_
8. ADCC(antibody-dependent cell-mediated cytotoxicity) ",wv*z)_>
&8VB{S>r
9. SH-2(src-homology region 2) [I/f(GK
Y
1e>P
10. Ab2¦Â (internal image) k.Tu#7
yEYlQ= [#
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© r\6 "mU
Jpi\n-
d!
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? )$18a
1J8okBhZ
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? z}I4m
K$>C*?R
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠRw4"co6
Vc}#Ok
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ hoy+J/
IyTL|W6
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠJw%0t'0Zi
]{->/.oB
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) 7^Y "K
u,<#z0R|;$
ÃâÒßѧרҵ£º c^^[~YWj
>;@ _TAF
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ 1mT3$Z
5GD6%{\O
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? Ns.b8Y
r)$(>/[$
´«È¾²¡Ñ§×¨Òµ£º Ktrqrl^IJ
_jmkA meu
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ jkd'2
iN\D`9e
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ -)%l{@Mr
C[h"w'A2
Ïû»¯×¨Òµ£º
M1><K:
KCR6@{@
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ <ptZY.8N
>5Vv6_CI0?
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? > %5<fK2
Q[t|+RNKv2
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ (UWV#AR
E"p;
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© d(u"^NH;
=FXO 1UZ!
1. Fas(CD95)/FasL 1-`Il]@?8
p8CDFLuV
2. common chain of cytokine receptor ,tt]C~\u
n&V \s0
3 . TCR/CD3 complex
X 4\
`9IG/
/
4. negaive selection of thymocytes }GV5':W@WG
Ae,P&(
5. artificial active immune xY]Y
7[=MgnmuC
6. anti-idiotypic g"pjWj)?
zo!e<>o
7. IgSF l423+vo
_ISIq3A?
8. Integrin >)E{Hs
cj=6_k
9. chemokine VJp; XM
NJ6*
7Cd
10. B7/CD28 z"[}Sk
Rn(6Fk?
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© m-%.LDqM
F#<$yUf%
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ rd#O ]
ZboY]1L[j
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ C"X; ,F<
X:3W9`s)*
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ nIWZo ~
aJAQ G
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ _VvXE572
$G
$147z
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ luPj'd?
5;:P^[cH9
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ y9/x:n&]
/b
]Yya#
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© p`oSI}ZwB
f`^\v
1. B7/CD28 J~"h&>T
_T8o]
2. Th1 subset =zetZJg
:4HZ>!i
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© liU/O:Ap
h#E ksX
4. antibody affinity maturation n91@{U)QJ3
x{|`q9V~ N
5. AP-1 CcDi65s
<"}Gvi
6. single chain variable fragment£¨ScFv£©
"3\C;B6I
6Z:swgi6&
7. NK cell receptor 2{`[<w
8Ev,9
8. Zinkernagel-Doherty phenomenon rB<za I\V
:t'*fHi~
9. Ig fold XZ3)gYQi
}}cS-p
10. CD40/CD40L |IgH0
zZ
@ff83Bg
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© 5Vj t!%?r
Fh3>y2`/
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ mv0JD(
X
/
{;
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ,[j'OyR
REaU=-m-
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
>bo_
I8%2tLVY
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ 8rXQK|A
P_:~!+W,
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ kM>Bk\
"'8^OZR
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ >w}5\4j
}CoR$K
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
^kElb;d
(oKrIm
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© T]#S=]G
R54wNm@
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© [RqL0EP
M
yv
yp
1.Co-stimulators (or co-stimulating molecules) /&`sB|
ioZ{2kK
2.NK-kB x'c%w:
(H/2{##
3.Immunoglobulin superfamily *G6Py,- !f
lO=Nw+'$S
4.antigen-presenting cell (APC) LMF@-j%
KO ~_
5.death domain ?aMV{H*Q*
)Td;2
6.CCR and CXCR Tf|?j=f
.d4L@{V
7.Lectin (or mitogen) %+=y!
m#^ua^JV
8.Clusters of differentiation, CD) 91Fx0(
^~iFG+g5
9.B7 family 0pC}+
+
ixf~3Y8
10.Cytotoxic T lymphocyte, CTL) ^uDNArDmj5
b%TS37`^[
11.IL-15 and IL-15 receptor (IL-15R) EGY'a*]cU
24}?GO
12.MHC restriction 3Y
L
-Tzp;o
13.Affinity-chromatography l$1z%|I
QXQ'QEG
14.Cyctosprin A, CsA n'
XvPV|
&7}\mnhB
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 8@}R_GZc
`Wes!>Vh!
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© u(Y! _
%X--`91|u
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 >I~$h,
8Moe8X#3
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
*tWZ.I<<
DaA9fJ7a
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ rzR=% >
TjU
g8k
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© AM[#AZv
TL29{'4V
ÃâÒßѧרҵ£º aB=&X